Pharmaceuticals

Even Small Financial Incentives Influence Prescribing Habits

Reported receipt of any non-research support from pharmaceutical manufacturers, regardless of amount, was associated with an almost doubled probability of a prostaglandin drug Rx.
08/02/2022

Study: Two-thirds of Patients Have Skin Reactions to Topical Ophthalmic Meds

Active ingredients, especially aminoglycoside antibiotics, were the main cause.
07/19/2022

Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections

Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.
05/11/2022

Managing Pediatric Ocular Pathology

Safe treatment of these patients requires a comprehensive understanding of available therapeutics.
03/15/2022

Update your Glaucoma Prescribing Protocols

Treatment options continue to evolve, with new meds and methods to consider.
03/15/2022

Hearing Loss a Possible Complication of Thyroid Eye Disease Drug

A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.
03/08/2022

Teprotumumab Promising as Treatment For Proptosis, Diplopia

Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.
02/25/2022

Oral CAIs More Safe Than Many Believe

The risk of adverse events was comparable to that of topical formulations, study finds.
02/01/2022

First Presbyopia Eye Drop Approved

The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.
10/29/2021

TNS Safe Treatment for Ocular Pain

Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.
06/01/2021

Upcoming Events

September 9-11, 2022

New Technologies & Treatments in Eye Care—San Antonio
Location: Omni La Mansion Del Rio
Program Chair: Paul Karpecki, OD, FAAO
Earn up to 19 COPE Credits (approval pending)

Register here

September 16, 2022

Establishing a Partnership in the Effective Management of Patients with Diabetic Retinal Disease
Location: Canaletto Las Vegas
Speakers: Nathan C. Steinle, MD and Jeffry Gerson, OD, FAAO
7:30–8:30pm PST

Sponsored by Regeneron

Register here

November 11-13, 2022

New Technologies & Treatments in Eye Care—Orlando
Location: Hilton Orlando Buena Vista Palace
Program Chair: Paul Karpecki, OD, FAAO
Earn up to 19 COPE Credits (approval pending)

Register here